DK3233108T3 - Hurtigtvirkende insulinsammensætninger - Google Patents

Hurtigtvirkende insulinsammensætninger Download PDF

Info

Publication number
DK3233108T3
DK3233108T3 DK15817678.4T DK15817678T DK3233108T3 DK 3233108 T3 DK3233108 T3 DK 3233108T3 DK 15817678 T DK15817678 T DK 15817678T DK 3233108 T3 DK3233108 T3 DK 3233108T3
Authority
DK
Denmark
Prior art keywords
fast
acting insulin
insulin compositions
compositions
acting
Prior art date
Application number
DK15817678.4T
Other languages
English (en)
Inventor
Michael Patrick Akers
Ranajoy Majumdar
Chi A Nguyen
Chad D Paavola
Virender Kumar Sarin
Nanette Elizabeth Schulte
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=55066806&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3233108(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of DK3233108T3 publication Critical patent/DK3233108T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK15817678.4T 2014-12-16 2015-12-09 Hurtigtvirkende insulinsammensætninger DK3233108T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462092407P 2014-12-16 2014-12-16
PCT/US2015/064744 WO2016100042A1 (en) 2014-12-16 2015-12-09 Rapid-acting insulin compositions

Publications (1)

Publication Number Publication Date
DK3233108T3 true DK3233108T3 (da) 2022-04-11

Family

ID=55066806

Family Applications (1)

Application Number Title Priority Date Filing Date
DK15817678.4T DK3233108T3 (da) 2014-12-16 2015-12-09 Hurtigtvirkende insulinsammensætninger

Country Status (17)

Country Link
US (3) US9993555B2 (da)
EP (2) EP4108253A1 (da)
JP (4) JP6328855B2 (da)
AR (1) AR102869A1 (da)
DK (1) DK3233108T3 (da)
ES (1) ES2911207T3 (da)
HR (1) HRP20220692T1 (da)
HU (1) HUE058764T2 (da)
LT (1) LT3233108T (da)
MA (1) MA41188B1 (da)
MD (1) MD3233108T2 (da)
PL (1) PL3233108T3 (da)
PT (1) PT3233108T (da)
RS (1) RS63174B1 (da)
SI (1) SI3233108T1 (da)
TW (1) TW201630622A (da)
WO (1) WO2016100042A1 (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2910570B1 (en) 2008-03-18 2016-10-12 Novo Nordisk A/S Protease stabilized, acylated insulin analogues
CN104902922B (zh) 2012-11-13 2017-12-12 阿道恰公司 包含经取代阴离子化合物的速效胰岛素制剂
AR102869A1 (es) * 2014-12-16 2017-03-29 Lilly Co Eli Composiciones de insulina de rápida acción
JO3749B1 (ar) 2015-08-27 2021-01-31 Lilly Co Eli تركيبات إنسولين سريعة المفعول
GB201607918D0 (en) 2016-05-06 2016-06-22 Arecor Ltd Novel formulations
JP7145849B2 (ja) * 2016-09-29 2022-10-03 アレコル リミテッド 新規の製剤
SI3554534T1 (sl) 2016-12-16 2021-09-30 Novo Nordisk A/S Farmacevtski sestavki, ki vsebujejo inzulin
US20180236080A1 (en) * 2017-02-22 2018-08-23 Adocia Fast-acting insulin composition comprising a citric acid salt
CN110582264B (zh) * 2017-03-26 2022-11-11 V·R·斯塔福德 眼睑皮肤状况的处理方法
JOP20190277B1 (ar) * 2017-06-01 2023-09-17 Lilly Co Eli تركيبات إنسولين سريعة المفعول
WO2019193349A1 (en) 2018-04-04 2019-10-10 Arecor Limited Medical infusion pump system for the delivery of an insulin compound
IL277720B2 (en) 2018-04-04 2024-03-01 Arecor Ltd A medical infusion pump system for administration of an insulin compound
EP3773474A1 (en) 2018-04-04 2021-02-17 Arecor Limited Medical infusion pump system for the delivery of an insulin compound
WO2019243627A1 (fr) 2018-06-23 2019-12-26 Adocia Dispositif pour injecter une solution d'insuline(s)
FR3083985A1 (fr) 2018-07-23 2020-01-24 Adocia Dispositif pour injecter une solution d'insuline(s)
CA3129569A1 (en) * 2019-03-14 2020-09-17 Thomas Weimbs Methods and compositions for supporting renal health
US10639328B1 (en) * 2019-03-27 2020-05-05 College Of William & Mary Compositions and methods for reducing hyperglycemia and treating diabetes
US10799564B1 (en) 2019-05-06 2020-10-13 Baxter International Inc. Insulin premix formulation and product, methods of preparing same, and methods of using same
WO2021055505A2 (en) * 2019-09-17 2021-03-25 Cass Pharmaceuticals, Inc. Subcutaneously injectable insulin and glucagon formulations and methods of administration
CN115176155A (zh) 2019-10-25 2022-10-11 塞卡科实验室有限公司 指示剂化合物、包括指示剂化合物的装置及其制备和使用方法
GB202004814D0 (en) 2020-04-01 2020-05-13 Arecor Ltd Novel formulations

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK116527B (da) 1967-03-01 1970-01-19 Nordisk Insulinlab Fremgangsmåde til fremstilling af en hurtigtvirkende, holdbar, neutral opløsning af rent krystallinsk okseinsulin eller okseinsulin, der ved tilsætning af Zn er krystalliserbart i vand, eller blandinger af okseinsulin og insulin af anden oprindelse.
DE3064888D1 (en) 1979-04-30 1983-10-27 Hoechst Ag Aqueous solutions of proteins stable against denaturization, process for their manufacture, and their utilization
FI78616C (fi) 1982-02-05 1989-09-11 Novo Industri As Foerfarande foer framstaellning av en foer infusionsaendamaol avsedd stabiliserad insulinloesning, som har en foerhoejd zinkhalt.
US4839341A (en) * 1984-05-29 1989-06-13 Eli Lilly And Company Stabilized insulin formulations
PH25772A (en) 1985-08-30 1991-10-18 Novo Industri As Insulin analogues, process for their preparation
NO162160C (no) 1987-01-09 1989-11-15 Medi Cult As Serumfritt vekstmedium, samt anvendelse derav.
DE10075034I1 (de) 1987-02-25 2001-05-23 Novo Nordisk As Insulinderivate
JPH04502465A (ja) 1988-12-23 1992-05-07 ノボ　ノルディスク　アクティーゼルスカブ ヒトインシュリン類似物質
US5716927A (en) 1988-12-23 1998-02-10 Novo Nordisk A/S Insulin analogs having a modified B-chain
US5474978A (en) 1994-06-16 1995-12-12 Eli Lilly And Company Insulin analog formulations
US6258341B1 (en) 1995-04-14 2001-07-10 Inhale Therapeutic Systems, Inc. Stable glassy state powder formulations
US5912014A (en) 1996-03-15 1999-06-15 Unigene Laboratories, Inc. Oral salmon calcitonin pharmaceutical products
US5866538A (en) 1996-06-20 1999-02-02 Novo Nordisk A/S Insulin preparations containing NaCl
AUPO066096A0 (en) 1996-06-26 1996-07-18 Peptide Delivery Systems Pty Ltd Oral delivery of peptides
DE69924232D1 (de) 1998-01-09 2005-04-21 Novo Nordisk As Stabilisierte insulin-zubereitungen
JP2002535287A (ja) 1999-01-26 2002-10-22 イーライ・リリー・アンド・カンパニー 単分散性６量体のアシル化されたインスリンアナログ製剤
WO2001035943A2 (en) 1999-11-15 2001-05-25 Gangal Hanamaraddi T Dextrose and insulin fluid formulation for intravenous infusion
JP4147234B2 (ja) 2004-09-27 2008-09-10 キヤノン株式会社 吐出用液体、吐出方法、カートリッジ及び吐出装置
US20020141946A1 (en) 2000-12-29 2002-10-03 Advanced Inhalation Research, Inc. Particles for inhalation having rapid release properties
DE10114178A1 (de) 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
DE10227232A1 (de) 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Saure Insulinzubereitungen mit verbesserter Stabilität
JP4800959B2 (ja) 2003-11-13 2011-10-26 ノヴォ ノルディスク アー／エス 糖尿病及び過食症を治療するためのｇｌｐ−１ペプチド及び短時間作用型インスリンペプチドを含む、非経口投与用の可溶性医薬組成物
US20080090753A1 (en) 2004-03-12 2008-04-17 Biodel, Inc. Rapid Acting Injectable Insulin Compositions
ES2398318T3 (es) 2004-03-12 2013-03-15 Biodel, Inc. Composiciones de suministro de fármacos de acción rápida
US7713929B2 (en) * 2006-04-12 2010-05-11 Biodel Inc. Rapid acting and long acting insulin combination formulations
US8084420B2 (en) 2005-09-29 2011-12-27 Biodel Inc. Rapid acting and long acting insulin combination formulations
US20070086952A1 (en) 2005-09-29 2007-04-19 Biodel, Inc. Rapid Acting and Prolonged Acting Inhalable Insulin Preparations
AU2007238114B2 (en) 2006-04-12 2010-10-14 Biodel, Inc. Rapid acting and long acting insulin combination formulations
US8084022B2 (en) 2006-06-23 2011-12-27 Aegis Therapeutics, Llc Stabilizing alkylglycoside compositions and methods thereof
WO2008013955A2 (en) 2006-07-27 2008-01-31 Nektar Therapeutics Sustained release formulations for pulmonary delivery
JP5552046B2 (ja) * 2007-06-13 2014-07-16 ノボ・ノルデイスク・エー／エス インスリン誘導体を含有する薬学的製剤
EP2036539A1 (en) 2007-09-11 2009-03-18 Novo Nordisk A/S Stable formulations of amylin and its analogues
TWI394580B (zh) 2008-04-28 2013-05-01 Halozyme Inc 超快起作用胰島素組成物
US9060927B2 (en) 2009-03-03 2015-06-23 Biodel Inc. Insulin formulations for rapid uptake
US20120094902A1 (en) 2009-03-27 2012-04-19 Adocia Fast-acting insulin formulation
FR2943538B1 (fr) 2009-03-27 2011-05-20 Adocia Formulation a action rapide d'insuline recombinante humaine
PL2612677T3 (pl) 2009-06-26 2015-10-30 Novo Nordisk As Preparat zawierający insulinę, nikotynamid i argininę
CA2805031A1 (en) 2010-07-07 2012-01-12 Biodel, Inc. Compositions and methods for modulating the pharmacokinetics and pharmacodynamics of insulin
BR112013032396A2 (pt) 2011-06-17 2016-11-22 Halozyme Inc formulações estáveis de aplicações relacionadas à enzima de degradação de ácido hialurônico
EA201400030A1 (ru) 2011-06-17 2014-07-30 Галозим, Инк. Способ непрерывного подкожного введения инсулина с использованием фермента, разрушающего хиалуронан
US9993529B2 (en) 2011-06-17 2018-06-12 Halozyme, Inc. Stable formulations of a hyaluronan-degrading enzyme
US20130231281A1 (en) * 2011-11-02 2013-09-05 Adocia Rapid acting insulin formulation comprising an oligosaccharide
RS59703B1 (sr) 2011-12-30 2020-01-31 Halozyme Inc Varijante ph20 polipeptida, njihove formulacije i upotrebe
US9399065B2 (en) * 2012-04-16 2016-07-26 Biodel Inc. Magnesium compositions for modulating the pharmacokinetics and injection site pain of insulin
US9381247B2 (en) 2012-04-16 2016-07-05 Biodel Inc. Magnesium compositions for modulating the pharmacokinetics and pharmacodynamics of insulin and insulin analogs, and injection site pain
US20150174209A1 (en) 2012-05-25 2015-06-25 Amylin Pharmaceuticals. Llc Insulin-pramlintide compositions and methods for making and using them
CN104902922B (zh) * 2012-11-13 2017-12-12 阿道恰公司 包含经取代阴离子化合物的速效胰岛素制剂
US20150065423A1 (en) 2013-08-30 2015-03-05 Perosphere, Inc. Rapid acting injectable formulations
CA2936563A1 (en) 2014-01-13 2015-07-16 Thermalin Diabetes, Llc Rapid action insulin formulations and pharmaceutical delivery systems
WO2015120457A1 (en) 2014-02-10 2015-08-13 Biodel Inc. Stabilized ultra-rapid-acting insulin formulations
US9795678B2 (en) 2014-05-14 2017-10-24 Adocia Fast-acting insulin composition comprising a substituted anionic compound and a polyanionic compound
AR102869A1 (es) * 2014-12-16 2017-03-29 Lilly Co Eli Composiciones de insulina de rápida acción
JO3749B1 (ar) * 2015-08-27 2021-01-31 Lilly Co Eli تركيبات إنسولين سريعة المفعول

Also Published As

Publication number Publication date
JP2023011641A (ja) 2023-01-24
EP3233108B1 (en) 2022-03-30
US20160166695A1 (en) 2016-06-16
JP2018500314A (ja) 2018-01-11
MA41188A (fr) 2017-10-24
MD3233108T2 (ro) 2022-09-30
US9993555B2 (en) 2018-06-12
JP6328855B2 (ja) 2018-05-23
JP2021073187A (ja) 2021-05-13
HUE058764T2 (hu) 2022-09-28
PT3233108T (pt) 2022-05-05
EP4108253A1 (en) 2022-12-28
RS63174B1 (sr) 2022-05-31
US11872266B2 (en) 2024-01-16
WO2016100042A1 (en) 2016-06-23
US20190231851A1 (en) 2019-08-01
US20220072105A1 (en) 2022-03-10
JP2018138578A (ja) 2018-09-06
HRP20220692T1 (hr) 2022-07-08
TW201630622A (zh) 2016-09-01
JP7093669B2 (ja) 2022-06-30
LT3233108T (lt) 2022-05-10
US11123406B2 (en) 2021-09-21
JP7159277B2 (ja) 2022-10-24
AR102869A1 (es) 2017-03-29
EP3233108A1 (en) 2017-10-25
PL3233108T3 (pl) 2022-06-20
SI3233108T1 (sl) 2022-05-31
ES2911207T3 (es) 2022-05-18
MA41188B1 (fr) 2022-08-31

Similar Documents

Publication Publication Date Title
DK3536380T3 (da) Hurtigtvirkende insulinsammensætninger
DK3233108T3 (da) Hurtigtvirkende insulinsammensætninger
DK3215173T3 (da) Glycopeptidsammensætninger
DK3040326T3 (da) Haloolefin-baseret sammensætning
BR112017001922A2 (pt) composições fungicidas
DK3334726T3 (da) Plinabulinsammensætninger
DK3110442T3 (da) Modificerede meningokok-fhbp-polypeptider
DK3223827T3 (da) Kostfibersammensætning
FR3024363B1 (fr) Composition thermogelifiable
DK3171700T3 (da) Infusionsanlæg
DK3250182T3 (da) Dispergible sammensætninger
DE112015001664A5 (de) Betätigungsaktuator
BR112016030730A2 (pt) Composto
CL2017000639A1 (es) Composición
DK3191466T3 (da) Azetidinyloxyphenylpyrrolidinforbindelser
DK3331498T3 (da) Nasalsammensætning
FR3020948B1 (fr) Composition antimicrobienne
DK3397734T3 (da) Brændstofsammensætning
DK3316857T3 (da) Multifasiske sammensætninger
DE112015005041A5 (de) Gargerätevorrichtung
EA202092926A3 (ru) Лиофилизированные составы, содержащие фактор ix
DK3393254T3 (da) Sammensætning
DK3200827T3 (da) Sammensætninger
DE102014000623A8 (de) Halbhohlnietelement
BR112017016240A2 (pt) composição